Avenue Colonel debate cholangiocarcinoma ca 19 9 cea index of markers Peck Anoi Avenue
CA 19-9 Antigen - an overview | ScienceDirect Topics
The Impact of Preoperative CA19-9 and CEA on Outcomes of Patients with Intrahepatic Cholangiocarcinoma | SpringerLink
Frontiers | Importance of Normalization of Carbohydrate Antigen 19-9 in Patients With Intrahepatic Cholangiocarcinoma
KoreaMed Synapse
Measurement of Serum Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, Cytokeratin-19 Fragment and Matrix Metalloproteinase-7 for Detecting Cholangiocarcinoma: A Preliminary Case-Control Study | Anticancer Research
JPM | Free Full-Text | Liver Tumor Markers, HALP Score, and NLR: Simple, Cost-Effective, Easily Accessible Indexes for Predicting Prognosis in ICC Patients after Surgery
Combinatorial Serum Markers for CCA Diagnosis | Download Scientific Diagram
The Highest Ever Reported Level of Carbohydrate Antigen 19-9: A Case Report | Al-Khallaf | Journal of Medical Cases
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
The Highest Ever Reported Level of Carbohydrate Antigen 19-9: A Case Report | Al-Khallaf | Journal of Medical Cases
PDF] Serum Markers of Intrahepatic Cholangiocarcinoma | Semantic Scholar
Common benign HPB conditions with associated deranged CA19.9 level | Download Table
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma
Clinical Significance of Preoperative Serum CEA, CA125, and CA19-9 Levels in Predicting the Resectability of Cholangiocarcinoma
PDF] Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. | Semantic Scholar
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
Longitudinal analysis of CA19‐9 reveals individualised normal range and early changes before development of biliary tract cancer in patients with primary sclerosing cholangitis - Wannhoff - 2019 - Alimentary Pharmacology & Therapeutics - Wiley Online ...
PDF] State of serum markers for detection of cholangiocarcinoma. | Semantic Scholar
Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - ScienceDirect
PDF) CA 19?9 and CE A are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis | Einar Björnsson - Academia.edu
Biomarkers of intrahepatic cholangiocarcinoma: diagnosis and response to therapy
The Impact of Preoperative CA19-9 and CEA on Outcomes of Patients with Intrahepatic Cholangiocarcinoma | SpringerLink
Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy | Anticancer Research
Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - Clinical Gastroenterology and Hepatology